Background illustration for clinical trials search

Paid Clinical Trials Missouri

Discover 1,809 paid clinical trials in Missouri. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

for
Liver Fibrosis, Hepatic Cirrhosis
Location: Morehead City NC, Raleigh NC, Jupiter FL, Miami FL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07610837

Phase 2, Recruiting

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

for
Lupus Nephritis
Location: West Long Branch NJ, Willow Grove PA, Rockville MD,
Sponsor: Aurinia Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07611214

Recruiting

Multicontext Approach for Cognitive Function in Parkinson Disease

for
PARKINSON DISEASE (Disorder)
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 50+

Code: NCT07190404

Recruiting

Menopausal HT for Women Living With HIV (HoT)

for
HIV Infection, Menopause
Location: Boston MA, New York NY, Newark NJ, Philadelphia PA,
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Sex: Female

Age: 40 - 60

Code: NCT06856174

Recruiting

Patient Position Monitoring System for Beam Gated Radiation Therapy of Malignancies of the Chest and Upper Abdomen

for
Radiotherapy, Radiotherapy, Image-Guided
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07373496

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

for
Core Binding Factor Acute Myeloid Leukemia
Location: Boston MA, Providence RI, The Bronx NY, Wilkes-Barre PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT06917911

Phase 2, Recruiting

Therapeutic RSK1 Targeting in Myeloid Malignancies

for
Myeloid Malignancy
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07379125

Phase 1, Recruiting

SGLT2 Inhibitors in Geographic Atrophy

for
Retinal Degeneration, Retinal Diseases, Eye Diseases,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 50+

Code: NCT07174687

Phase 2, Recruiting

PREcision MEDicine In Achalasia (PREMEDIA) - Cohort

for
Type III Achalasia,
Location: Boston MA, Charlotte NC, Gainesville FL, Cleveland OH,
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07293689

Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

for
Macular Edema Secondary to Inflammation
Location: Boston MA, Waterford CT, Manchester CT, Greenwich CT,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06996080

Phase 3, Recruiting

Randomized Withdrawal Study in Patients With Schizophrenia

for
Schizophrenia
Location: Staten Island NY, Marlton NJ, North Miami FL,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT06961968

Phase 3, Recruiting

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

for
Multiple Sclerosis (MS) Primary Progressive
Location: Livingston NJ, Raleigh NC, Orlando FL, Maitland FL,
Sponsor: Zenas BioPharma (USA), LLC

Sex: All

Age: 18 - 60

Code: NCT07067463

Phase 3, Recruiting

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Charleston SC, Augusta GA, Greenville SC, Anderson SC,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06279013

Recruiting

Horizon Two: HR NDMM (MMRC-100)

for
High Risk Newly Diagnosed Multiple Myeloma
Location: Boston MA, New York NY, Chapel Hill NC, Charlotte NC,
Sponsor: Multiple Myeloma Research Consortium

Sex: All

Age: 18+

Code: NCT07053436

Phase 2, Recruiting

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

for
CLL, Chronic Lymphocytic Leukemia
Location: Shirley NY, Westbury NY, New York NY, Greenfield Park,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06846671

Phase 3, Recruiting

ELEVATE High-Risk PCI Pivotal Study

for
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
Location: Boston MA, Worcester MA, Manhasset NY, New York NY,
Sponsor: Magenta Medical Ltd.

Sex: All

Age: 18 - 70+

Code: NCT07001332

Recruiting

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

for
Urothelial Cancer, Urinary Bladder Neoplasms
Location: Chicoutimi, New York NY, Montreal, Norfolk VA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07566156

Phase 3, Recruiting

Treatment of Antibody-Mediated Rejection (ABMR) With CarBel

for
Kidney Transplant Rejection
Location: New York NY, Durham NC, Cleveland OH, Cincinnati OH,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT06918990

Phase 1, Recruiting

A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System

for
Severe Aortic Stenosis, Valve-in-valve Procedures
Location: Boston MA, The Bronx NY, Baltimore MD, Clearwater FL,
Sponsor: Anteris Technologies Ltd.

Sex: All

Age: 18+

Code: NCT07194265

Recruiting

A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States

for
Advanced Unresectable Gastric Adenocarcinoma,
Location: Coral Springs FL, Tamarac FL, Plantation FL, Hialeah FL,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07554521

Phase 2, Recruiting

Popular cities in Missouri

With its expansive healthcare network and renowned medical research institutions, Missouri is a central hub for a diverse range of clinical trials. Leading organizations such as Washington University School of Medicine in St. Louis, the University of Missouri Health Care, and St. Louis University are at the forefront of groundbreaking studies. These institutions drive innovation in medical research and offer unique opportunities for participants to engage in cutting-edge clinical trials, contributing to advancements in healthcare both locally and nationwide.

Why choose Missouri for clinical trials?

Missouri has a diverse population which ensures a wide variety of participants can take part in clinical trials, enhancing the accuracy, applicability, and validity of clinical research findings. The state is also home to a thriving research environment, with a strong emphasis on medical innovation and cutting-edge studies led by world-class institutions.

By choosing to participate in a clinical trial in Missouri, individuals contribute to critical advancements in medical research while benefiting from a well-established and supportive clinical research infrastructure.

Common conditions studied in Missouri

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Missouri